1. Market Research
  2. > Vital Signs - The Analyst's Perspective - February 2015 Issue

This issue of Vital Signs, released on March 2, 2015, discusses the US President's science budget, Pfizer's acquisition of Hospira, China's redefined Foreign Investment Law, and President Obama's Precision Medicine Initiative.

Table Of Contents

Vital Signs - The Analyst's Perspective - February 2015 Issue
First Look at President's Science Budget 2
Pfizer Acquires Hospira: An Expensive Investment for a Dud? 3
China Redefines the Foreign Investment Law 4
FACT SHEET: President Obama's Precision Medicine Initiative 6

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.